Natco Pharma Limited has informed the Exchange regarding a press release dated January 30, 2026, titled "Disclosure under Regulation 30 of SEBI (LODR) Regulations, 2015".
NATCOPHARM · price
▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.
Awaiting price reaction for this filing.
Natco Pharma has submitted a press release dated January 30, 2026, to the stock exchange as required under Regulation 30 of the SEBI Listing Obligations and Disclosure Requirements (LODR) Regulations. Regulation 30 filings are typically used to disclose material events or information that could affect the company's stock price or shareholder decisions. The exact details or topic of the press release have not been included in the filing text provided here, so the specific subject matter (such as earnings, a new product, a regulatory update, or a corporate action) cannot be confirmed from the available information.
Without the actual content of the press release, the impact on shareholders or the stock price cannot be determined. Investors should check Natco Pharma's investor relations page or the NSE/BSE corporate announcements section for the full press release to understand what has been disclosed.